Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review

被引：2
|
作者：
Tang, Zhiwei [1 ]
Ji, XiuHai [2 ]
Zhou, Guanghui [1 ]
Chen, Ruhua [1 ]
Fen, Yan [1 ]
Ding, Hui [1 ]
机构：
[1] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Pulm & Crit Care Med, Yixing, Peoples R China
[2] Affiliated Taicang Hosp Tradit Chinese Med, Dept Oncol, Taicang, Peoples R China
来源：
ANTI-CANCER DRUGS | 2022年 / 33卷 / 01期
关键词：
afatinib; epidermal growth factor receptor; hypotension; lung cancer;
D O I：
10.1097/CAD.0000000000001244
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Side effects of afatinib are a problem in patients with advanced non-small cell lung cancer (NSCLC). However, little is known about the occurrence of afatinib-induced hypotension. An 81-year-old man with NSCLC had an epidermal growth factor receptor-positive genotype with the p.L861Q mutation in exon 21. He was administered afatinib (40 mg/day) as anticancer therapy. Hypotension occurred twice after afatinib initiation. He suffered from dizziness and nausea. Blood pressure gradually returned to normal after afatinib cessation. Clinicians should be aware of hypotension in patients with NSCLC after afatinib initiation.
引用
收藏
页码：E840 / E841
页数：2
相关论文
共 50 条
  • [1] Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer-case report
    Mueser, Nino Rafael
    Kirchbacher, Klaus
    Funk, Georg-Christian
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (02) : 107 - 109
  • [2] Osimertinib a new weapon in epidermal growth factor receptor-mutated non-small cell lung cancer patients
    Rossi, Antonio
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S610 - S613
  • [3] Mathematical analysis identifies the optimal treatment strategy for epidermal growth factor receptor-mutated non-small cell lung cancer
    Yu, Qian
    Kobayashi, Susumu S.
    Haeno, Hiroshi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Histologic transformation of epidermal growth factor receptor-mutated lung cancer
    Fujimoto, Daichi
    Akamatsu, Hiroaki
    Morimoto, Takeshi
    Wakuda, Kazushige
    Sato, Yuki
    Kawa, Yoshitaka
    Yokoyama, Toshihide
    Tamiya, Motohiro
    Hiraoka, Ryota
    Shingu, Naoki
    Ikeda, Hideki
    Tamiya, Akihiro
    Kanazu, Masaki
    Miyauchi, Eisaku
    Miura, Satoru
    Yanai, Masaaki
    Yomota, Makiko
    Morinaga, Ryotaro
    Yokoi, Takashi
    Hata, Akito
    Suzuki, Hidekazu
    Matsumoto, Hirotaka
    Sakata, Shinya
    Furuya, Naoki
    Harutani, Yuhei
    Nakachi, Ichiro
    Otsuki, Ayumu
    Uematsu, Shinya
    Hara, Satoshi
    Yokoo, Keiki
    Sugimoto, Takeya
    Yamamoto, Nobuyuki
    EUROPEAN JOURNAL OF CANCER, 2022, 166 : 41 - 50
  • [5] Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer
    Li, Yuan-yuan
    Lam, Sze-kwan
    Mak, Judith Choi-wo
    Zheng, Chun-yan
    Ho, James Chung-man
    LUNG CANCER, 2013, 81 (03) : 354 - 361
  • [6] Moving osimertinib to first-line: the right "strategy" in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?
    Passiglia, Francesco
    Raez, Luis E.
    Rolfo, Christian
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1076 - S1080
  • [7] The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study
    Ding, P. N.
    Becker, T. M.
    Bray, V. J.
    Chua, W.
    Ma, Y. F.
    Lynch, D.
    Po, J.
    Luk, A. W. S.
    Caixeiro, N.
    de Souza, P.
    Roberts, T. L.
    LUNG CANCER, 2019, 134 : 187 - 193
  • [8] Risk factors of acquired T790M mutation in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Huang, Zhao
    Chen, Gang
    Liu, Yu
    Liao, Zhengkai
    Zeng, Wei
    Zhang, Junhong
    Xie, Conghua
    JOURNAL OF CANCER, 2020, 11 (08): : 2060 - 2067
  • [9] Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer -: A review of the literature
    Araujo, Antonio
    Ribeiro, Ricardo
    Azevedo, Isabel
    Coelho, Ana
    Soares, Marta
    Sousa, Berta
    Pinto, Daniela
    Lopes, Carlos
    Medeiros, Rui
    Scagliotti, Giorgio V.
    ONCOLOGIST, 2007, 12 (02) : 201 - 210
  • [10] Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
    Nokihara, Hiroshi
    Ogino, Hirokazu
    Mitsuhashi, Atsushi
    Kondo, Kensuke
    Ogawa, Ei
    Ozaki, Ryohiko
    Yabuki, Yohei
    Yoneda, Hiroto
    Otsuka, Kenji
    Nishioka, Yasuhiko
    BMC CANCER, 2022, 22 (01)
12345